Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...

Prostate cancer is the second leading cause of cancer deaths in men, according to the South Carolina Department of Public ...

PALM SPRINGS, Calif. (KESQ) -The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate cancer cases on the rise across the nation ...

reducing the number of patients who had notable worsening in symptoms from 34 per cent to 16 per cent. Niraparib is approved in the UK to treat some types of cancer, but has not yet been approved for ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

MEN with aggressive prostate cancer could benefit from a new drug combination that slows cancer growth, scientists say. Adding a drug already used against ovarian and fallopian tube cancers to ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...

It turns out that, for men, ejaculating very regularly could also significantly reduce the risk of prostate cancer. The ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.